The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results of a phase III randomized, controlled study of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukemia (CLL).
 
Jeffrey Alan Jones
Consulting or Advisory Role - Genentech/Abbvie; Janssen; Pharmacyclics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Genentech/Abbvie (Inst); Gilead Sciences (Inst); MedImmune (Inst); Pharmacyclics (Inst)
 
Tadeusz Robak
Research Funding - Gilead Sciences
 
Malgorzata Wach
Research Funding - Gilead Sciences
 
Jennifer R. Brown
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; ProNAi; Roche/Genentech; Sun Pharma
 
Alexander R. Menter
Research Funding - Gilead Sciences
 
Elizabeth Vandenberghe
Research Funding - Gilead Sciences
 
Loic Ysebaert
Research Funding - Gilead Sciences
 
Nina D. Wagner-Johnston
Consulting or Advisory Role - Gilead Sciences; Pharmacyclics
Speakers' Bureau - Gilead Sciences
Research Funding - Celgene; Gilead Sciences
 
Jonathan Polikoff
Travel, Accommodations, Expenses - Genentech
 
Farrukh Tauseef Awan
Consulting or Advisory Role - Gilead Sciences; Novartis
Research Funding - Innate Pharma
 
Xavier Camille Albert Badoux
Research Funding - Gilead Sciences
 
Steven Coutre
Stock and Other Ownership Interests - Pharmacyclics (I)
Consulting or Advisory Role - Abbvie; Celgene; Genentech/Roche; Gilead Sciences; Novartis; Pharmacyclics
Research Funding - Abbvie (Inst); Celgene (Inst); Gilead Sciences (Inst); Novartis (Inst); Pharmacyclics (Inst)
Travel, Accommodations, Expenses - abbvie; Celgene; Gilead Sciences; Novartis; Pharmacyclics
 
Stephen Edward Forbes Spurgeon
Research Funding - Gilead Sciences
 
Javier Loscertales
Research Funding - Gilead Sciences
 
Lyndah Dreiling
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Guan Xing
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Sissy Peterman
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Ronald L. Dubowy
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Ian Flinn
Research Funding - Gilead Sciences
 
Carolyn Owen
Honoraria - Abbvie; Gilead Sciences; Janssen; Lundbeck; Roche
Speakers' Bureau - Roche
Research Funding - Gilead Sciences